Skip to content

A Randomized Trial of Recruitment Strategies for Research Participation

A Randomized Trial of Recruitment Strategies for Research Participation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02697799
Enrollment
1296
Registered
2016-03-03
Start date
2016-08-31
Completion date
2019-08-31
Last updated
2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incentives, Research Ethics

Brief summary

In a multicenter, randomized clinical trial of attitudes towards research participation, we will evaluate the ethics, effectiveness, and cost- effectiveness of three recruitment strategies for research participation in a mobility trial among hospitalized patients and a smoking cessation trial among patients with depression.

Interventions

BEHAVIORALHigh-level recruitment strategy consent form

Patients will be exposed to pre-consent messaging and a consent form that includes supplemental information describing a high-level recruitment strategy

BEHAVIORALMid-level recruitment strategy consent form

Patients will be exposed to pre-consent messaging and a consent form that includes supplemental information describing a mid-level recruitment strategy

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Washington University School of Medicine
CollaboratorOTHER
M.D. Anderson Cancer Center
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Eligible for parent RCT 2. 18 years or older 3. No prior knowledge of recruitment strategies used for this trial 4. Speaks English

Exclusion criteria

1)Prior knowledge of recruitment strategies used for this trial

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome is the proportion of people assigned to each recruitment strategy that consent to participate in the two parent RCTs.Immediate- Several DaysConsent rates in each of the two parent RCTs

Secondary

MeasureTime frameDescription
Attention to informed consentImmediateWe will assess the amount of time patients spend reading each part of the parent RCT consent forms. On-site research coordinators will facilitate the collection of this data as patients read the document via the recruitment strategy study's electronic database.
Perceived risks of the researchImmediatePerceived risks of the research will be measured by the 9-item compared riskiness scale, which assesses perceptions of research risk. Using this approach, patients compare their assessment of the riskiness of the RCTs to other salient and more commonly encountered risks. Such comparative assessments have been shown to be less susceptible to errors in scale calibration than isolated ratings of risks.
Incidence of therapeutic misconceptionsImmediateWe will assess patients' ability to distinguish research from individualized patient care by measuring rates of therapeutic misconception across recruitment strategies among patients considering participation in the parent RCTs. We will assess this outcome with a 4-item tool developed by Dr. Scott Kim, which has been used for similar purposes in several research contexts.
Attitudes towards researchImmediateAttitudes towards research will be measured using the Research Attitudes Questionnaire-7 (RAQ-7). Originally designed with 11 items, a shorter 7-item version (RAQ-7) has been shown to have improved internal consistency and factorial validity.
Perceptions of influence or coercionImmediateTo measure general perception of coercion and voluntariness of research participation, we will use the five-item Perceived Coercion Scale of the MacArthur Admission Experience Survey. The true/false scale is tailored to measure patients' perceptions of coercion in the inpatient psychiatric treatment admission process; we have edited the wording to make it relevant to participation in the parent RCTs.
Retention through the end of treatment sessions8 - 27 weeksWe will assess the impact of the recruitment strategies on retention status in the protocol of the parent RCTs.
Understanding of the trialImmediateTo assess whether increased attention translates into improved understanding of the parent RCTs, we will use a 6-item Trial Elements Quiz, featuring core elements of the parent RCTs' consent form.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026